Innovations in localized renal cell carcinoma (RCC): From biomarkers and molecular imaging to stereotactic body radiation therapy (SBRT).
This recording explores the key innovations in the management of localised renal cell carcinoma (RCC).
Through expert insights on stereotactic body radiotherapy (SBRT), biomarkers, and molecular imaging, we aim to clarify how these emerging tools can refine patient selection, improve treatment response assessment, and enhance disease characterisation.
The recording addresses ongoing challenges in integrating novel technologies into clinical pathways and assess whether these approaches are ready for broader implementation.
By bringing multidisciplinary expertise together, this recording seeks to offer practical answers and perspectives on how to personalise care and push the boundaries of the current RCC management.
Speakers:
- Dr. M.C. Mir Maresma (ES)
- Dr. L. Marandino (GB)
- Dr. G. Francolini (IT)
- Prof. Dr. P. Ost (BE)
- Dr. Z. Tippu (GB)
- Dr. R. Campi (IT)
- Assoc. Prof. D. Amparore (IT)
This recording is brought to you in collaboration with the EAU Young Urology Office and Young Academic Urologists.
🌟 Important info: The recording of this webinar is not EU-ACME accredited. Missed the live session? Earn 1 CME point by completing our online e-course at: https://uroweb.org/education-events/education?page=1&type=e-course. Don’t miss this opportunity! 🎓💡